Details for Patent: 4,454,152
✉ Email this page to a colleague
Summary for Patent: 4,454,152
Title: | Methoxsalen dosage forms |
Abstract: | This invention relates to oral dosage forms wherein the active ingredient, methoxsalen, is dispersed in a water-soluble composition containing a polyethylene glycol or mixtures of polyethylene glycols. Dissolution of methoxsalen in gastrointestinal fluids as well as drug absorption are more rapid and higher blood level patterns are achieved with these dosage forms as compared to conventional encapsulated dosage forms. |
Inventor(s): | Barry; Richard H. (Bloomfield, NJ), Lazarus; Jack H. (Jersey City, NJ) |
Assignee: | Hoffmann-La Roche Inc. (Nutley, NJ) |
Application Number: | 06/332,982 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; | More… ↓ |
Drugs Protected by US Patent 4,454,152
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,454,152
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 545363 | ⤷ Subscribe | |||
Australia | 7006981 | ⤷ Subscribe | |||
Canada | 1173751 | ⤷ Subscribe | |||
Denmark | 193381 | ⤷ Subscribe | |||
European Patent Office | 0039874 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |